DMEI provides more than 225,000 total patient visits per year from all 77 Oklahoma counties and the surrounding six-state region through its main location on the University of Oklahoma Health Sciences Center campus in Oklahoma City and four satellite locations.
According to the foundation, the grants were awarded to 18 investigators at prominent universities in the United States, Nigeria, and Hong Kong.
Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.
According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.
The trial evaluated nesvategrast (OTT166 5%) eye drops in patients with diabetic retinopathy.
The reverse stock split is “part of the Company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market."
Alexander Movshovich, MD, PhD, a specialist in keratopigmentation, sat down to talk about the controversy surrounding the procedure after it went viral on social media.
Patients who underwent LASIK had undergone phacoemulsification 7 years earlier compared to a matched control group, according to the study authors.
Even small changes can have a large impact, saving time for physicians.
Study demonstrates that patients achieved long-term visual acuity gains following CureSight treatment.
OCU410 is a modifier gene therapy candidate being developed for geographic atrophy, an advanced stage of dry age related macular degeneration.
Scientists at the Doheny Eye Institute, in collaboration with UCLA chemists, demonstrate how a single gene mutation in an enzyme complex known to produce the energy required by cells causes a sudden, blinding disease.
The transient receptor potential melastatin 8 (TRPM8) are cold-sensitive thermoreceptors that play central role in tear film homeostasis
The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.
The collaboration combines Clario's transformative technology with Cleveland Clinic's market-leading imaging expertise and AI-enabled analysis to help bring new therapies to patients, faster.
Ophthalmologists can educate their patients about the importance of using certified solar viewing glasses or other safe viewing methods.
Vermont is the latest state to consider legislation expanding the scope of practice for optometrists. Earlier this year, South Dakota became the 12th state to expand the scope of practice for optometrists.
The organization aims to educate viewers of dangers and safety precautions ahead of the eclipses.
LL-BMT1 is a novel, preservative-free, weekly drug-eluting contact lens created by the company’s proprietary 3D printing technology.
Cyclosporine superior to vehicle, improves corneal staining in dry eye disease
Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation
Investigators emphasized that the data does not indicate a causal relationship between eye disorder and systemic diseases.
In the study, published in Nature Biotechnology, researchers used their new system to correct disease-causing mutations in the eyes of two mouse models of genetic blindness, partially restoring their vision.
Their machine-learning multistage system predicts the expected disease progression of patients and their VA with age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).
The study showed that a 12-day treatment of KIO-101 topically at multiple doses was well tolerated in healthy volunteers and patients with inflammation of the eye.
Results show Eylea HD extended dosing regimens were non-inferior to aflibercept 2 mg injection (Eylea) for both the treatment of wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).
TL-925 is a first in class, topical Bruton’s tyrosine kinase (BTK) inhibitor that prevents mast cell activation and degranulation, and also blocks the cytokine-driven inflammatory response, and restores lacrimal unit homeostasis, offering the potential for disease modification
Jeff Todd, president and CEO of Prevent Blindness, and astrophotographer Jon Carmichael sat down with David Hutton of Ophthalmology Times to talk about how ophthalmologists can help make sure patients are viewing the eclipse safely as well as proper ways to view/photograph the event without damaging your eyes or equipment.
According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.
.png "Optometry Times"){kind=logo}
